Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission
University of Freiburg · University Hospital of Basel · +35 more institutions
Abstract
The development of curative and regenerative therapies that go beyond the largely symptomatic treatment options available; and (6) deployment of public health preventive strategies for banning smoking and maintaining clean air. We are fully cognisant that the scientific evidence to support some of our proposals is lacking. However, it is the intention of the Commission to generate discourse and debate, catalyse momentum, and provide a much-needed new vision to set the course towards the elimination of COPD.
Citation impact
- FWCI
- 84.16
- Percentile
- 100%
- References
- 352
Authors
29- DSDaiana Stolz
University of Freiburg, University Hospital of Basel
- TMTakudzwa Mkorombindo
University of Alabama at Birmingham
- DSDesirée Schumann
University Hospital of Basel
- ÀAÀlvar Agustí
Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Hospital Clínic de Barcelona, Universitat de Barcelona
- SYSamuel Y. Ash
Brigham and Women's Hospital, Harvard University
Topics & keywords
- Medicine
- COPD
- Intensive care medicine
- Disease
- Population
- Spirometry
- Public health
- Environmental health
- Good health and well-being
Funding
- UDU.S. Department of Defense
- AAmgen
- ALAmerican Lung Association
- PPfizer
- AAstraZeneca
- GGlaxoSmithKline
- SSanofi
- GSGilead Sciences
- TPTeva Pharmaceutical Industries
- UTUnited Therapeutics Corporation
- RHRespiratory Health Association
- CFCOPD Foundation
- SSunovion
- RPRegeneron Pharmaceuticals
- MMylan
- NBNGM Biopharmaceuticals
- IInsmed
- GGrifols
- MBMereo BioPharma
- NINational Institutes of HealthAwards: HL122464, U01 HL-139466, R01 HL116473
- NHNational Heart, Lung, and Blood InstituteAwards: U01 HL-139466, R01 HL122464, R01 HL116473, K23HL153672